By Edward Winnick and Tony Fong

SAN FRANCISCO (GenomeWeb News) – The second day of the JP Morgan Conference included presentations from several of molecular tools and molecular diagnostics bellwethers, including Thermo Fisher Scientific and Qiagen, as well as single-molecule sequencing firm Pacific Biosciences.

Below is a recap of their pitches to investors and other issues discussed during their breakout sessions.

Thermo Fisher Scientific

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.